...
机译:升高的血浆PCSK9水平对非血密高胆固醇血症和杂合族家族性高胆固醇血症的患者同样有害,无论低密度脂蛋白受体缺损如何
Faculté de Médecine Université de Nantes UMR PhAN 1280 1 Place Alexis Ricordeau 44093 Nantes;
Lipid Research Group Heart Research Institute Sydney Australia Centre for Vascular Research;
Faculté de Médecine Université de Nantes UMR PhAN 1280 1 Place Alexis Ricordeau 44093 Nantes;
Lipidology Division of Internal Medicine MRC Cape Heart Group University of Cape Town Cape Town;
Lipid Research Group Heart Research Institute Sydney Australia;
Lipid Research Group Heart Research Institute Sydney Australia Centre for Vascular Research;
Lipid Research Group Heart Research Institute Sydney Australia;
Lipid Research Group Heart Research Institute Sydney Australia Centre for Vascular Research;
Royal Perth Hospital Department of Clinical Biochemistry PathWest Laboratory of Medicine Perth;
Royal Perth Hospital Department of Clinical Biochemistry PathWest Laboratory of Medicine Perth;
Lipid Research Group Heart Research Institute Sydney Australia Centre for Vascular Research;
Chemical Pathology Division of Clinical Laboratory Sciences Health Science Faculty University of;
familial hypercholesterolemia; LDL receptor; LDL-cholesterol; PCSK9;
机译:升高的血浆PCSK9水平对非血密高胆固醇血症和杂合族家族性高胆固醇血症的患者同样有害,无论低密度脂蛋白受体缺损如何
机译:AMG 145的低密度脂蛋白胆固醇降低作用,对杂合子家族性高胆固醇血症患者的前蛋白转化酶枯草杆菌蛋白酶/ kexin 9型丝氨酸蛋白酶的单克隆抗体:PCSK9抑制可降低LDL-C对杂合子家族性高胆固醇血症(RUTHERFORD)的影响试用
机译:低密度脂蛋白受体基因突变K790X在日本人杂合性家族性高胆固醇血症男性中将冠状动脉扩张与血浆胰岛素水平相关联。
机译:SCD40L的血浆水平与家族性高胆固醇血症(FH)临床诊断患者的HDL-胆固醇和APOA-1相关。
机译:未治疗的杂合子或纯合子家族性高胆固醇血症患者的PCSK9水平升高以及对大剂量他汀类药物治疗的反应
机译:血浆中PCSK9水平升高对非家族性高胆固醇血症和杂合子型家族性高胆固醇血症的患者均有害,而与低密度脂蛋白受体缺陷无关